Vax Before Cancer

 / December 2nd, 2022

Eliminating fake vaccine news with pharmacist, nurse, and physician review.

Nov 22 • 6:56 am CST
Northwest Biotherapeutics reported that in its Phase III clinical trial, median survival and the “long tail” of extended survival increased in newly diagnosed and recurrent glioblastoma brain cancer patients treated with DCVax®-L. The trial results published...
Nov 8 • 2:15 pm CST
Immunomic Therapeutics, Inc., a clinical-stage biotechnology company pioneering the development of LAMP-mediated nucleic acid-based immunotherapy, today announced that the U.S. FDA granted Fast Track Designation to the ITI-3000 program for treating patients with Merkel cell carcinoma...
Nov 8 • 7:29 am CST
Geneos Therapeutics announced positive safety and efficacy data from the first 24 patients enrolled in GT-30. GT-30 is an ongoing single-arm open-label multi-center Phase 1b/2a study to evaluate safety, immunogenicity, and efficacy of PTCV (GNOS-PV02) administered...
Nov 7 • 9:29 am CST
Apros Therapeutics, Inc. today announced that they would present interim pharmacokinetic and pharmacodynamic Phase 1 clinical data for APR003, a first-in-class orally-administered gastrointestinal (GI)- and liver-targeted TLR7 agonist. It is currently being evaluated in an ongoing...
Nov 3 • 5:53 am CDT
Transgene announced that following an interim analysis of its randomized controlled Phase II clinical study comparing TG4001 in combination with avelumab to avelumab alone in patients with HPV16- positive anogenital tumors, the Independent Data Monitoring Committee...

For more articles, try our search.